Real-time
Other stock markets
|
5-day change | 1st Jan Change | ||
210 EUR | +0.62% | -15.53% | -12.32% |
Apr. 23 | SARTORIUS STEDIM BIOTECH : Barclays reaffirms its Neutral rating | ZD |
Apr. 22 | Sartorius Stedim: in the red with brokerage comments | CF |
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
SubscribeEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-12.32% | 21.73B | |
-2.25% | 187B | |
-1.32% | 108B | |
-3.92% | 67.71B | |
+7.99% | 53.07B | |
+15.74% | 47.36B | |
+6.01% | 39.73B | |
+10.81% | 28.56B | |
+2.34% | 26.55B | |
+15.97% | 25.13B |
- Stock Market
- Equities
- DIM Stock
- News Sartorius Stedim Biotech
- Transcript : Sartorius Aktiengesellschaft, Sartorius Stedim Biotech S.A., Q1 2023 Earnings Call, Apr 20, 2023